ARCHIVED - Anthrax


Nationally notifiable since 2002

1.0 National Notification

Confirmed, probable and suspect cases of disease should be notified.

2.0 Type of Surveillance

Routine case-by-case notification to the federal level

3.0 Case Classification

3.1 Confirmed case

Clinical illness with laboratory confirmation of infection:

  • Isolation of Bacillus anthracis in a clinical specimen
  • Demonstration of B. anthracis in a clinical specimen by immunofluorescence

3.2 Probable case

Suspected case with detection of B. anthracis DNA

3.3 Suspect Case

Clinical illness in a person who is epidemiologically linked to a confirmed or suspected animal case or contaminated animal product

4.0 Laboratory Comments

5.0 Clinical Evidence


Clinical illness is characterized by the appearance of small, painless but often pruritic papules. As the papule enlarges, it becomes vesicular and, within two days, ulcerates to form a distinctive black eschar, with surrounding edema


Clinical illness is characterized by an upper-respiratory flu-like syndrome that, after a few days, takes a fulminant course, manifested by dyspnea, cough, chills and a high-grade bacteremia.


Clinical illness is characterized by abdominal pain, fever and signs of septicaemia.

6.0 ICD Code(s)

6.1 ICD-10 Code(s)

6.2 ICD-9 Code(s)

7.0 Type of International Reporting


9.0 References

Wilson RW, Sande MA. Current Diagnosis and Treatment of Infectious Diseases. McGraw-Hill Professional, 2001.

Date of Last Revision/Review:

May 2008

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: